Monoamine oxidase B and Parkinson's disease
- 20 January 1990
- journal article
- other
- Published by Elsevier in The Lancet
- Vol. 335 (8682) , 180
- https://doi.org/10.1016/0140-6736(90)90063-b
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- Metabolism of the neurotoxic tertiary amine, MPTP, by brain monoamine oxidasePublished by Elsevier ,2004
- Effect of Deprenyl on the Progression of Disability in Early Parkinson's DiseaseNew England Journal of Medicine, 1989
- The Effect of Deprenyl (Selegiline) on the Natural History of Parkinson's DiseaseScience, 1989
- S-METHYLATION IN MOTORNEURON DISEASE AND PARKINSON'S DISEASEThe Lancet, 1989
- Simultaneous determination of levodopa, carbidopa, 3-O-methyldopa and dopamine in plasma using high-performance liquid chromatography with electrochemical detectionJournal of Pharmaceutical and Biomedical Analysis, 1987
- Monoamine oxidase B, smoking, and Parkinson's diseaseJournal of the Neurological Sciences, 1986
- Increased life expectancy resulting from addition of l-deprenyl to Madopar® treatment in Parkinson's disease: A longterm studyJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1985